Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply ○
found
a story from The Guardian ⚠️ › International
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
found
a story from The Guardian ⚠️ › International
Fierce competition and threat of Trump tariffs lead to Danish company cutting costs
Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and …